Finland · research

Rappta Therapeutics

Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.

PrivateFor profit

researchHelsingfors, Finland

Against its peers

Set against 3,254 research companies worldwide. The ring marks the typical peer.

Staff11-50The typical size for its peers
Founded200612 years before the typical peer (2018)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 40% of those with a founding year.

About Rappta Therapeutics

What it does

BiopharmaBiotechnologyLife Science

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$9.0M

raised in total, currency not stated across 1 round

Last raised Oct 2020, 6 years ago

Rounds
1
Latest round
Series a
Investors
32 leading

Key facts

Who started it and how it trades.

Founded by
George Trainor, Goutham Narla

Every detail we hold

Everything the source datasets list about Rappta Therapeutics, field by field. Contact details are held but never shown.

The company7 fields

Name
Rappta Therapeutics
Type
For profit
Status
Private
Founded
2006
Founders
George Trainor, Goutham Narla
Industry
research
Categories
Biopharma, Biotechnology, Life Science

Where3 fields

City
Helsingfors
Country
Finland
Markets
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)

Size and reach1 field

Staff band
11-50
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
9,000,000 (currency not stated)
Rounds
1
Latest round
Series a
Latest round date
Oct 2020
Investors
3
Lead investors
2
Listing status
private

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Rappta Therapeutics may be growing as evidenced by the company's involvement in various capacities within the biopharmaceutical industry. The company is mentioned in the context of stock and other ownership interests, which suggests that it is recognized in the investment community and may have a shareholder base that is interested in its growth potential. Additionally, the mention of Rappta Therapeutics alongside other companies in a scientific advisory or consultancy capacity indicates that it is engaged in collaborative efforts or providing expertise in its field, which can be indicative of operational growth and industry recognition. Furthermore, the company's inclusion in a list with other notable entities such as Alligator, Silverback, and Gilead reflects its presence and potential activity within the biopharma and biotechnology sectors.

Companies like Rappta Therapeutics

research in Finland.

Build a lead list

Every research company, filtered by size, age and reach, ready to export with emails on Pro.

Open the list